Novos Boost (NMN) 125 mg: DSLD label record for a capsule
The DSLD record lists Novos Boost (NMN) 125 mg as a capsule from brand Novos, declaring 250 mg beta-nicotinamide mononucleotide per labelled serving. The record is a label declaration only and does not establish efficacy, safety or approval. [1]
Automatic summary · not editorially reviewed
FROM THE ORIGINAL LABEL
A closer look at the product
- Pack contents
- 60 Capsule(s)
- Label serving
- 2 Capsule(s)
- Servings per container
- 30
Ingredients & declared amounts1
Amounts from the label, per specified serving. These are manufacturer declarations, not a personal dosage recommendation.
| Ingredient | Amount | Per label serving |
|---|---|---|
| Beta-Nicotinamide Mononucleotide | 250 mg | 2 Capsule(s) |
Other ingredients: Cellulose
Source: National Institutes of Health, Office of Dietary Supplements · Dietary Supplement Label Database. Label snapshot; packaging and formulation may have changed.
The key findings
The source at a glance
- Brand
- Novos
- Form
- Capsule
- Pack contents
- 60 Capsule(s)
- Label serving
- 2 Capsule(s)
- Ingredients listed
- Beta-Nicotinamide Mononucleotide
- Record type / format
- Dietary supplement label/database record
- Scope / context
- The described product: Novos Boost (NMN) 125 mg capsules, brand Novos.
- Summary based on
- Product label / database record
Novos capsule record in the DSLD
This is record 304580 in the NIH Dietary Supplement Label Database. The label name is Novos Boost (NMN) 125 mg, the declared brand is Novos and the physical form on the label is capsule. The database places it in the category Non-Nutrient/Non-Botanical. The label entered the database on 2024-03-22; the record notes this is not a product launch date.
Supporting source [1]
Declared ingredient: 250 mg NMN per serving
The only declared ingredient with an amount is beta-nicotinamide mononucleotide, listed at 250 mg per labelled serving. This is a label fact, not a dosing recommendation. The record supplies no independent product testing, no price and no batch certificate.
Supporting source [1]
What the DSLD listing does not show
Inclusion in the DSLD does not establish efficacy, safety, FDA approval, laboratory verification or current retail availability. The snapshot describes label declarations only. The product name contains NMN, but the record itself reports no study, no outcome and no comparison.
Supporting source [1]
How to interpret this
Product label record; not evidence of efficacy or approval. The record contains label declarations only, with no independent testing, price, batch certificate or study data.
Based on a product label or database record. This does not establish effectiveness, independent batch testing, approval or current availability.
Source & supporting passages
Novos · dsld.od.nih.gov